CTSA Supplements for Pediatrics/BPCA-Due April 30
NCRR announces the availability of CTSA Administrative Supplements to support research on pediatric outcome measures relevant to the Best Pharmaceuticals for Children Act (BPCA). These are one-year awards in an anticipated amount of $50,000-$500,000 per project. A maximum of $5,000,000 may be provided for this solicitation. Applications should be submitted to NCRR's, Dr. Mary Purucker, using form PHS 398 and accompanied by a cover letter. This solicitation closes April 30 at 5:00 p.m. EDT. Awards will be made by September 30. Click here http://grants.nih.gov/grants/guide/notice-files/NOT-RR-09-005.html for more information. These awards are being made in partnership with the National Institute of Child Health & Human Development (NICHD). Please direct any administrative questions Dr. Purucker (puruckerm@mail.nih.gov). Scientific or technical questions related to the Best Pharmaceuticals for Children Act should be directed to NICHD's, Dr. Anne Zajicek (zajiceka@mail.nih.gov).